Clinical trial
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
NCT00003110 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003110 |
|---|---|
| Title | Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma |
| Official title | A Phase II Trial of 72-Hour Continuous Infusion Bleomycin as Salvage Therapy in AIDS-Related and Immunocompetent Non-Hodgkin's Lymphoma |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | bleomycin sulfate |
| Enrollment | 5 |
| Start date | Jul 1, 1997 |
| Primary completion | Aug 1, 2001 |
| Completion | Dec 1, 2002 |
| First posted | Apr 7, 2004 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: